Treatment Outcome of Neurogenic Bladder Dysfunction in Children; A Five-Year Experience

Objective: A neurogenic bladder is one which functions abnormally due to disorders of sacral nerves that control the bladder's ability to fill, store and empty urine. Abnormal bladder function can cause the bladder to be underactive or overactive. This study was planned to evaluate the treatment outcome of our patients with neurogenic bladder dysfunction (NGBD). Methods: Thirty three patients who have been treated for NGBD were evaluated. Diagnosis was confirmed by voiding-cysto-urethrography (VCUG) and urodynamic study. The patients were treated medically and all had clean intermittent catheterization (CIC). Data regarding age, sex, clinical and paraclinical findings, sonography, imagings, renal scan, associated anomalies, treatment and outcomes were collected and entered in SPSS software version18 and analyzed by descriptive statistical. Findings : Totally 33 patients aged three days to four years (mean 6.8 months) were included in this study. There were 20 (61%) males and 13 (39%) females. Mean follow-up period was 3.4±1.2 years (1.5 months to 5 years). Eighty two precent cases had bilatral and 18% unilatral hydronephrosis and bilatral vesicouretral reflux (VUR) existed in 67% and unilatral in 33% of the patients. Treatment consisted of antibiotherapy and CIC in all patients, which was only in 33% of the cases succesful. The most common associated anomaly was meningomyelocle in 8 patients. Vesicostomy was performed in 22 (67%) cases. Kidney scan showed scar in 10 patients at follow-up study. Complete continence on follow-up was achieved in 24 (71% ) patients, and it was improved in 6 (18% ) cases. Mortality rate was 9% (3 cases). Cure rate was 85% in urinary tract infection, 82.7% in hydronephrosis, 80% in VUR and 86.5% in kidney function. Conclusion: Anticholinergic medications was not effective in all our patients. We believe that permanent vesicostomy is an effective and acceptable surgical intervention for protection of upper urinary tract decompression, especially in those who do not respond to medical treatment and have high risk position.

[1]  L. Mohajerzadeh,et al.  Protective Temporary Vesicostomy for Upper Urinary Tract Problems in Children: A Five-Year Experience , 2013, Iranian journal of pediatrics.

[2]  A. Mirshemirani,et al.  Posterior Urethral Valves; A single Center Experience , 2013, Iranian journal of pediatrics.

[3]  K. Murphy,et al.  Cerebral palsy, neurogenic bladder, and outcomes of lifetime care , 2012, Developmental medicine and child neurology.

[4]  D. Goossens,et al.  Evolution of the management of acquired neurogenic bladder in children using intradetrusor botulinum toxin type A injections: 5-year experience and perspectives. , 2012, Journal of pediatric urology.

[5]  J. Stoffel,et al.  Management goals for the spina bifida neurogenic bladder: a review from infancy to adulthood. , 2010, The Urologic clinics of North America.

[6]  J. Pannek,et al.  EAU guidelines on neurogenic lower urinary tract dysfunction. , 2009, European urology.

[7]  P. Dik,et al.  Early start to therapy preserves kidney function in spina bifida patients , 2007, Cerebrospinal Fluid Research.

[8]  G. Kramer,et al.  Guidelines on neurogenic lower urinary tract dysfunction. , 2007, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[9]  M. Chancellor,et al.  Pharmacotherapy for Neurogenic Detrusor Overactivity , 2006, American journal of physical medicine & rehabilitation.

[10]  P. Dik,et al.  Early start to therapy preserves kidney function in spina bifida patients. , 2006 .

[11]  J. Djurhuus,et al.  The outcome of detrusor myotomy in children with neurogenic bladder dysfunction. , 2004, The Journal of urology.

[12]  P. Lertsithichai,et al.  Follow-up of long-term treatment with clean intermittent catheterization for neurogenic bladder in children. , 2004, Asian journal of surgery.

[13]  P. Rubenwolf.  [Prognostic value of urodynamic testing in myelodysplastic patients]. , 2003, Aktuelle Urologie.

[14]  R. Hohenfellner,et al.  Urinary diversion and orthotopic bladder substitution in children and young adults with neurogenic bladder: a safe option for treatment? , 2000, The Journal of urology.

[15]  S. Bauer,et al.  The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration. , 1992, American journal of diseases of children.

[16]  S. Shapiro,et al.  Fate of 90 children with ileal conduit urinary diversion a decade later: analysis of complications, pyelography, renal function and bacteriology. , 1975, The Journal of urology.

[17]  G. Kramer,et al.  Guidelines on neurogenic lower urinary tract dysfunction. , 2007, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[18]  L. Baskin,et al.  Surgical management of the neurogenic bladder and bowel. , 2003, International braz j urol : official journal of the Brazilian Society of Urology.